 | |
| Clinical data | |
|---|---|
| Trade names | Phenylpiracetam hydrazide |
| Other names | Fonturacetam hydrazide |
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C12H15N3O2 |
| Molar mass | 233.271 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| |
| |
 N Y (what is this?) (verify) | |
Phenylpiracetam hydrazide, also known asfonturacetam hydrazide,[1] is aracetam that is aderivative ofphenylpiracetam in which theamide group is replaced with ahydrazide group.[2] It was first reported by a Russian research group in 1980 as part of a series of chemical compounds investigated asanticonvulsants.[2][3] In an electroshock test it was found to have anED50 of 310 mg/kg.[3]
Allpiracetamderivatives are not permitted to be sold asdietary supplements in theUnited States.[4] However, because they lack scheduling, piracetam derivatives like phenylpiracetam hydrazide are sold over the clear net accompanied by indications stating that the compound is "not for human consumption".[2][5] Some report no effects, while others report a milder effect compared tophenylpiracetam.[2] Doses are 50 to 100 mg and above.[2]
